Daehan New Pharm Co. Ltd (054670) - Total Liabilities

Latest as of September 2025: ₩122.10 Billion KRW ≈ $82.74 Million USD

Based on the latest financial reports, Daehan New Pharm Co. Ltd (054670) has total liabilities worth ₩122.10 Billion KRW (≈ $82.74 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Daehan New Pharm Co. Ltd to assess how effectively this company generates cash.

Daehan New Pharm Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Daehan New Pharm Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Daehan New Pharm Co. Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Daehan New Pharm Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Daehan New Pharm Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Gedeon Richter PLC LSE:0QFP	UK	£249.71 Billion
HAZER Group Ltd AU:HZR	Australia	AU$4.04 Million
MMP Industries Limited NSE:MMP	India	Rs2.42 Billion
Mandom Indonesia Tbk JK:TCID	Indonesia	Rp530.70 Billion
Complete Solaria, Inc NASDAQ:SPWR	USA	$320.66 Million
Globe Metals & Mining Ltd AU:GBE	Australia	AU$5.42 Million
Zakłady Lentex SA WAR:LTX	Poland	zł93.79 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Daehan New Pharm Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 054670 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.94	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.49	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daehan New Pharm Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daehan New Pharm Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Daehan New Pharm Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩95.85 Billion ≈ $64.95 Million	+41.84%
2023-12-31	₩67.57 Billion ≈ $45.79 Million	+1.76%
2022-12-31	₩66.40 Billion ≈ $45.00 Million	-11.68%
2021-12-31	₩75.18 Billion ≈ $50.95 Million	-1.01%
2020-12-31	₩75.95 Billion ≈ $51.47 Million	+13.62%
2019-12-31	₩66.84 Billion ≈ $45.30 Million	+1.80%
2018-12-31	₩65.66 Billion ≈ $44.49 Million	-6.33%
2017-12-31	₩70.09 Billion ≈ $47.50 Million	+17.77%
2016-12-31	₩59.52 Billion ≈ $40.33 Million	+7.38%
2015-12-31	₩55.43 Billion ≈ $37.56 Million	-2.03%
2014-12-31	₩56.58 Billion ≈ $38.34 Million	--

About Daehan New Pharm Co. Ltd

KQ:054670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$67.63 Million

₩99.79 Billion KRW

Market Cap Rank

#20708 Global

#1251 in Korea

Share Price

₩7110.00

Change (1 day)

-0.14%

52-Week Range

₩6380.00 - ₩8380.00

All Time High

₩21012.38